104 related articles for article (PubMed ID: 34461577)
1. Colon cancer patients with mismatch repair deficiency are more likely to present as acute surgical cases.
Gkekas I; Novotny J; Kaprio T; Beilmann-Lehtonen I; Fabian P; Edin S; Strigård K; Svoboda T; Hagström J; Barsova L; Jirasek T; Haglund C; Palmqvist R; Gunnarsson U
Eur J Cancer; 2021 Nov; 157():1-9. PubMed ID: 34461577
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry testing for mismatch repair deficiency in Stage 2 colon cancer: A cohort study of two cancer centres.
Grant M; Haydon A; Au L; Wilkins S; Oliva K; Segelov E; Antill Y; Carne P; Ranchod P; Polglase A; Farmer C; Chin M; Wale R; Simpson P; Bell S; Skinner S; McMurrick P; Shapiro J
Int J Surg; 2018 Mar; 51():71-75. PubMed ID: 29367039
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study.
Tougeron D; Mouillet G; Trouilloud I; Lecomte T; Coriat R; Aparicio T; Des Guetz G; Lécaille C; Artru P; Sickersen G; Cauchin E; Sefrioui D; Boussaha T; Ferru A; Matysiak-Budnik T; Silvain C; Karayan-Tapon L; Pagès JC; Vernerey D; Bonnetain F; Michel P; Taïeb J; Zaanan A
J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 26839356
[TBL] [Abstract][Full Text] [Related]
4. Sporadic deficient mismatch repair in colorectal cancer increases the risk for non-colorectal malignancy: A European multicenter cohort study.
Gkekas I; Jan N; Kaprio T; Beilmann-Lehtonen I; Fabian P; Tavelin B; Böckelman C; Edin S; Strigård K; Svoboda T; Hagström J; Barsova L; Jirasek T; Haglund C; Palmqvist R; Gunnarsson U
J Surg Oncol; 2024 Mar; ():. PubMed ID: 38470492
[TBL] [Abstract][Full Text] [Related]
5. Lymph node yield after colectomy for cancer: is absence of mismatch repair a factor?
Samdani T; Schultheis M; Stadler Z; Shia J; Fancher T; Misholy J; Weiser MR; Nash GM
Dis Colon Rectum; 2015 Mar; 58(3):288-93. PubMed ID: 25664706
[TBL] [Abstract][Full Text] [Related]
6. Deficient mismatch repair as a prognostic marker in stage II colon cancer patients.
Gkekas I; Novotny J; Fabian P; Nemecek R; Palmqvist R; Strigård K; Pecen L; Svoboda T; Gurlich R; Gunnarsson U
Eur J Surg Oncol; 2019 Oct; 45(10):1854-1861. PubMed ID: 31186203
[TBL] [Abstract][Full Text] [Related]
7. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.
Sinicrope FA; Foster NR; Thibodeau SN; Marsoni S; Monges G; Labianca R; Kim GP; Yothers G; Allegra C; Moore MJ; Gallinger S; Sargent DJ
J Natl Cancer Inst; 2011 Jun; 103(11):863-75. PubMed ID: 21597022
[TBL] [Abstract][Full Text] [Related]
8. Colon cancer CT staging according to mismatch repair status: Comparison and suggestion of imaging features for high-risk colon cancer.
Hong EK; Chalabi M; Landolfi F; Castagnoli F; Park SJ; Sikorska K; Aalbers A; van den Berg J; van Leerdam M; Lee JM; Beets-Tan R
Eur J Cancer; 2022 Oct; 174():165-175. PubMed ID: 36029713
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of DNA mismatch repair-deficient gastric cancer in a Japanese hospital-based population.
Ito T; Suzuki O; Kamae N; Tamaru JI; Arai T; Yamaguchi T; Akagi K; Eguchi H; Okazaki Y; Mochiki E; Ishida H
Jpn J Clin Oncol; 2021 May; 51(6):886-894. PubMed ID: 33728435
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and predictive roles of DNA mismatch repair status in colon cancer patients treated with oxaliplatin-based chemotherapy: a retrospective study.
Qin Q; Zhou AP; Yang L; Xu C; Sun YK; Zhang W; Wang JW; Zhong DS
J Physiol Pharmacol; 2020 Aug; 71(4):. PubMed ID: 33316771
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy.
Sinicrope FA; Mahoney MR; Smyrk TC; Thibodeau SN; Warren RS; Bertagnolli MM; Nelson GD; Goldberg RM; Sargent DJ; Alberts SR
J Clin Oncol; 2013 Oct; 31(29):3664-72. PubMed ID: 24019539
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative opioids are associated with decreased recurrence rates in colon adenocarcinoma: a retrospective observational cohort study.
Yuval JB; Lee J; Wu F; Thompson HM; Verheij FS; Gupta HV; Irie T; Scarpa JR; McCormick PJ; Smith JJ; Shia J; Weiser MR; Sánchez-Vega F; Tan KS; Fischer GW; Garcia-Aguilar J; Mincer JS
Br J Anaesth; 2022 Aug; 129(2):172-181. PubMed ID: 35718564
[TBL] [Abstract][Full Text] [Related]
13. Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trials.
Sinicrope FA; Foster NR; Yoon HH; Smyrk TC; Kim GP; Allegra CJ; Yothers G; Nikcevich DA; Sargent DJ
J Clin Oncol; 2012 Feb; 30(4):406-12. PubMed ID: 22203756
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between mismatch repair proteins status and clinicopathological characteristics in sporadic colorectal cancer patients].
Xiao ZT; Zhang RX; Zhao Y; Peng JH; Lu SX; Zhang HZ; Ding PR; Wu XJ; Lu ZH; Li LR; Wan DS; Pan ZZ; Chen G
Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(16):1248-1251. PubMed ID: 28441855
[No Abstract] [Full Text] [Related]
15. Different surgical outcome and follow-up status between dMMR and pMMR colorectal cancer patients who fulfilled with Amsterdam-II criteria.
Sun CY; Chiang JM; Chen TC; Hung HY; You JF
World J Surg Oncol; 2020 Aug; 18(1):195. PubMed ID: 32767993
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of high-risk factors and
Zhang Y; Wu Z; Zhang B; Hu H; Zhang J; Chen Y; Ding M; Cao Y; Deng Y
Ann Transl Med; 2022 Jun; 10(12):702. PubMed ID: 35845506
[TBL] [Abstract][Full Text] [Related]
17. Survival outcome of adjuvant chemotherapy in deficient mismatch repair stage III colon cancer.
Shaib WL; Zakka KM; Jiang R; Yan M; Alese OB; Akce M; Wu C; Behera M; El-Rayes BF
Cancer; 2020 Sep; 126(18):4136-4147. PubMed ID: 32697360
[TBL] [Abstract][Full Text] [Related]
18. Teenage colorectal polyposis and cancer may be caused by constitutional mismatch repair deficiency (CMMRD).
Soplepmann J; Laidre P
Acta Oncol; 2016 Dec; 55(12):1503-1505. PubMed ID: 27723366
[No Abstract] [Full Text] [Related]
19. Identification of Comprehensive Biomarkers in Patients With Mismatch Repair-Deficient Colon Adenocarcinoma Based on Parallel Multiomics.
Li Z; Teng L; Pan Z; Yang Y; Zhu J; Wu X; Qian Y; Qian H; Bian Y; Chen Y; Chen W; Bi L
Lab Invest; 2024 Feb; 104(2):100306. PubMed ID: 38104864
[TBL] [Abstract][Full Text] [Related]
20. Colorectal Tumors From Different Racial and Ethnic Minorities Have Similar Rates of Mismatch Repair Deficiency.
Berera S; Koru-Sengul T; Miao F; Carrasquillo O; Nadji M; Zhang Y; Hosein PJ; McCauley JL; Abreu MT; Sussman DA
Clin Gastroenterol Hepatol; 2016 Aug; 14(8):1163-71. PubMed ID: 27046481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
